USPTO serial 79137568
PHARNEXT
Reviewed by CopyMark Law Group
Reg. 4611799Status 404
- Filing date
- Status date
- Registration date
- Sep 30, 2014
- Examiner
- HALMEN, KATHERINE E
- Law office
- POST REGISTRATION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHARNEXT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
FR
F-92130 ISSY-LES-MOULINEAUX, FR
F-92130 ISSY-LES-MOULINEAUX, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey A. Smith
Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.2200 Clarendon BoulevardSuite 1400Arlington, VA 22201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for medical purposes for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II; medicines, namely, medicines for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II; pharmaceutical preparations for human use for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis; diagnostic preparations for medical diagnosis purposes; chemicals preparations for medical purposes, namely, for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis; food supplements and nutritional supplements; dietetic food supplements for medical use; homeopathic and plant therapy compositions, namely, homeopathic supplements; sanitary preparations for medical use; pharmaceuticals preparations for skin care, hair care and hygiene; medical preparations for slimming; therapeutic medicated bath preparations; bath salts for medical use; dietary supplement beverages, namely, dietary supplemental drinks in the nature of vitamin and mineral beverages; appetite suppressants for medical use; barks for pharmaceutical use, namely, angostura bark for medical purposes, condurango bark for medical purposes, Croton bark for medical purposes and Croton bark for use as an anti-inflammatory; royal jelly for medical purposes; medicinal oils for medical use; chemical reagents for medical use, namely, biomarkers | SECTION 71 - CANCELLED | — |
| 035 | Database management and collection and compilation of information into computer databases in the field of medicine and clinical trials; compilation of statistics * in the field of medicine *; collection and systematization of information into computer databases * in the field of medicine *; public relations* in the field of medicine * ; communication, namely, promoting public awareness regarding disease treatments | SECTION 71 - CANCELLED | — |
| 041 | Training services in the field of medicine; publishing of books and texts * in field of medicine *, namely, press articles, magazines, brochures; electronic publishing services, namely, publication of texts works of others on-line in the field of medicine; educational services, namely, organization and conducting of colloquiums, conferences, conventions and seminars in the field of medicine for non-business and non-commercial purposes; * teaching in the field of medicine * | SECTION 71 - CANCELLED | — |
| 042 | Pharmaceutical research and development; scientific research in the field of medicine; conducting of clinical trials and studies; chemical and biological analysis; laboratory research in the field of cosmetics, chemistry, bacteriology, biology, biotechnology and nutrition; biological research for the diagnosis, prevention and treatment of diabetes and obesity and any other illness; biological research services in the field of chemicals, biological agents and pharmaceuticals; design and development of software * in the field of medicine *; scientific laboratory services; provision of information in the field of pharmaceuticals research, medical research and scientific research in the field of pharmaceuticals and clinical trials; chemical research on chemical reagents for medical use, namely, biomarkers | SECTION 71 - CANCELLED | — |
| 044 | Medical services; pharmaceutical advice | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PHARNEXT
- Other trademarks owned by PHARNEXT
- Other trademarks owned by PHARNEXT
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PHARNEXT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 6, 2024 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jan 6, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 17, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 9, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 4, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 22, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 22, 2022 | INPC | INVALIDATION PROCESSED | — |
| Dec 16, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 16, 2021 | C71T | CANCELLED SECTION 71 | — |
| Sep 30, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 6, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 7, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 8, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 26, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 23, 2016 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| May 15, 2016 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 15, 2015 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 15, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 30, 2015 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jun 29, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 15, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 6, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 31, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 31, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 30, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 30, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 15, 2014 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Sep 11, 2014 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 22, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 15, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 15, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 2, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 2, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 25, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 10, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 5, 2014 | ALIE | ASSIGNED TO LIE | — |
| May 22, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 22, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 22, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 22, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 22, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 7, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 7, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 6, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 6, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 23, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 7, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 7, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 7, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 6, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 28, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 28, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 25, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |